SAM
JSPR icon

Simplify Asset Management’s Jasper Therapeutics JSPR Stock Holding History

Simplify Asset Management’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-609,053
Closed -$1.45M – 152
2025
Q3 		$1.45M Buy
+609,053
New +$1.85M 0.03% 67
2025
Q1 		– Sell
-20,000
Closed -$428K – 100
2024
Q4 		$428K Buy
+20,000
New +$416K 0.02% 80

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Simplify Asset Management's JSPR Position: Q4 2025 in Review

Simplify Asset Management sold out of Jasper Therapeutics (JSPR) in Q4 2025, closing a stake of 609,053 shares — an estimated $1.45M sold.

Simplify Asset Management first reported a position in JSPR in Q4 2024 and held it in 2 quarters. The position peaked at $1.45M in Q3 2025. 55 funds tracked by Wall St. Rank hold JSPR as of Q4 2025.

  • Simplify Asset Management reported no remaining Jasper Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Simplify Asset Management sold 609,053 Jasper Therapeutics shares in Q4 2025, an estimated $1.45M.
  • Simplify Asset Management first reported a position in Jasper Therapeutics in Q4 2024 and held it in 2 quarters.
  • Simplify Asset Management's Jasper Therapeutics position peaked at $1.45M in Q3 2025.
  • 55 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q4 2025.

Based on Simplify Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.